JUPITER — A Scripps Florida scientist has won a five-year, $2.9 million grant to work on new treatments for leukemia, the nonprofit institute said Monday.
The $575,000-a-year grant will fund Scripps Florida’s efforts to develop new molecules that deliver cytotoxic drugs to leukemia cells without harming normal cells, said Christoph Rader, an associate professor of immunology and microbiology at Scripps Florida.
“It is a very precise architecture,” Rader said. “I call this molecular engineering. We are really on a molecular level putting parts together.”
Such an approach could reduce the side effects of cancer treatments, he said. If the research is successful, it would mark a step toward developing chemotherapy drugs that can distinguish between healthy tissue and tumors.
Hans Renata of Scripps Florida will work on the research with Rader.